Death Associated With Coronavirus (COVID-19) Infection in Individuals With Severe Mental Disorders in Sweden During the Early Months of the Outbreak-An Exploratory Cross-Sectional Analysis of a Population-Based Register Study

• Published in: Frontiers in psychiatry Vol. 11; p. 609579
• Main Authors: Maripuu, Martin, Bendix, Marie, Öhlund, Louise, Widerström, Micael, Werneke, Ursula
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 08.01.2021
• Subjects: bipolar disorder; coronavirus; COVID-19; death; Medicin och hälsovetenskap; mortality; Psychiatry; psychotic disorder; risk factors; severe mental disorder; COVID-19; bipolar disorder; risk factors; death; mortality; coronavirus; severe mental disorder; psychotic disorder
• ISSN: 1664-0640; 1664-0640
• DOI: 10.3389/fpsyt.2020.609579

Individuals with severe mental disorder (SMD) have a higher risk of somatic comorbidity and mortality than the rest of the population. We set up a population-based study to assess whether individuals with SMD had a higher risk of death associated with a COVID-19 infection (COVID-19 associated death) than individuals without SMD. Exploratory analysis with a cross-sectional design in the framework of a population-based register study covering the entire Swedish population. The Swedish Board for Health and Welfare (Socialstyrelsen) provided anonymized tabulated summary data for further analysis. We compared numbers of COVID-19 associated death in individuals with SMD (cases) and without SMD (controls). We calculated the odds ratio (OR) for the whole sample and by age group and four comorbidities, namely diabetes, cardiovascular disease, hypertension, chronic lung disease. The sample comprised of 7,923,859 individuals, 103,999 with SMD and 7,819,860 controls. There were 130 (0.1%) COVID-19 associated deaths in the SMD group and 4,945 (0.06%) in the control group, corresponding to an OR of 1.98 (CI 1.66-2.35; p < 0.001). The odds were 4-fold for the age groups between 60 and 79 years and 1.5-fold for cardiovascular diseases. Individuals with SMD without any of the risk factors under study had 3-fold odds of COVID-19 associated death. Our preliminary results identify individuals with SMD as a further group at increased risk of COVID-19 associated death. In regard to comorbidities, future studies should explore the potential confounding or mediation role in the relationship between SMD and COVID-19 associated deaths.